James A. Bolognese

Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial

Robert S. Bresalier, Robert S. Sandler, Hui Quan et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

Christopher P. Cannon, Sean Curtis, Garret A. FitzGerald et al. · The Lancet · 2006 · 520 citations

Rheumatoid Disorder, Rheumatology, Cardiovascular Disease +8

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2–specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis

Loren Laine, S. E. Harper, Thomas Simon et al. · Gastroenterology · 1999 · 476 citations

Anti-inflammatory, Gastrointestinal Pharmacology, Cyclooxygenase 2–Specific +9

Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis.

Elliot Ehrich, Gareth Roderique‐Davies, David J. Watson et al. · PubMed · 2000 · 433 citations

A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas

John A. Baron, Robert S. Sandler, Robert S. Bresalier et al. · Gastroenterology · 2006 · 431 citations · Full text

Chemoprevention Strategy, Gastroenterology, Colorectal Cancer +6